AR074801A1 - Monocarbamas y composiciones farmaceuticas que los contienen - Google Patents

Monocarbamas y composiciones farmaceuticas que los contienen

Info

Publication number
AR074801A1
AR074801A1 ARP090104977A ARP090104977A AR074801A1 AR 074801 A1 AR074801 A1 AR 074801A1 AR P090104977 A ARP090104977 A AR P090104977A AR P090104977 A ARP090104977 A AR P090104977A AR 074801 A1 AR074801 A1 AR 074801A1
Authority
AR
Argentina
Prior art keywords
hydrogen
methyl
independently selected
pharmaceutical
monocarbams
Prior art date
Application number
ARP090104977A
Other languages
English (en)
Inventor
Mark Edward Flanagan
Manjinder Singh Lall
Steven Joseph Brickner
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR074801A1 publication Critical patent/AR074801A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se refiere a composiciones farmacéuticas y a métodos para tratar infecciones bacterianas usando los compuestos de la fórmula (1). Reivindicación 1: Un compuesto caracterizado porque es de la fórmula (1), o una sal farmacéuticamente aceptable del mismo; en la que: R1 es alquilo C1-6 sustituido con 1 a 3 sustituyentes seleccionados del grupo que consiste en halo, hidroxi, alcoxi C1-6, -NR7R8, -C(=O)NR7R8, y un heterociclo de 3 a 7 miembros, en donde R7 y R8 son independientemente hidrógeno o alquilo C1-6, en donde dicho heterociclo contiene 1 a 3 heteroátomos seleccionados independientemente de O, N, o S; R2 es hidrógeno o metilo; R3 es hidrógeno o metilo; R4 es hidrógeno, deuterio o metilo opcionalmente sustituido con 1 a 3 sustituyentes seleccionados independientemente de F o CI; R5 es hidrógeno, deuterio o metilo opcionalmente sustituido con 1 a 3 sustituyentes seleccionados independientemente de F o CI; R6 es H o -C(=O)OH; y X es C(H), C(F), C(Cl), o N.
ARP090104977A 2008-12-19 2009-12-18 Monocarbamas y composiciones farmaceuticas que los contienen AR074801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13915908P 2008-12-19 2008-12-19

Publications (1)

Publication Number Publication Date
AR074801A1 true AR074801A1 (es) 2011-02-16

Family

ID=41727494

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090104977A AR074801A1 (es) 2008-12-19 2009-12-18 Monocarbamas y composiciones farmaceuticas que los contienen

Country Status (15)

Country Link
US (2) US8252782B2 (es)
EP (1) EP2379546A1 (es)
JP (1) JP2012512863A (es)
KR (1) KR20110086742A (es)
CN (1) CN102325769A (es)
AR (1) AR074801A1 (es)
AU (1) AU2009329169B2 (es)
CA (1) CA2744756C (es)
IL (1) IL213216A0 (es)
MX (1) MX2011006541A (es)
PA (1) PA8855001A1 (es)
SG (1) SG171781A1 (es)
TW (1) TW201026696A (es)
UY (1) UY32336A (es)
WO (1) WO2010070523A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010070523A1 (en) * 2008-12-19 2010-06-24 Pfizer Inc. Monocarbams
DK2646436T3 (en) 2010-11-29 2015-06-29 Pfizer monobactams
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
DK3353175T3 (da) * 2015-09-23 2020-09-14 Novartis Ag Salte og faste former af et monobactam-antibiotikum
CN105481812B (zh) * 2015-11-30 2020-04-21 重庆天奕恒化科技有限公司 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法
BR112019012994A2 (pt) 2016-12-21 2019-12-03 Aicuris Gmbh & Co Kg terapia de combinação com compostos de b-lactama de amidina substituída e inibidores de b-lactamase para infecções com cepas bacterianas resistentes a antibiótico
WO2019026004A2 (en) 2017-08-02 2019-02-07 Novartis Ag CHEMICAL PROCESS FOR THE PREPARATION OF ANTIBIOTIC MONOBACTAM AND ITS INTERMEDIATES
CN110997627B (zh) 2017-08-23 2023-10-10 亥姆霍兹感染研究中心有限公司 孢囊菌酰胺衍生物
JP7366746B2 (ja) 2017-08-31 2023-10-23 北興化学工業株式会社 １－（ｎ，ｎ－ジ置換カルバモイル）４－（置換スルホニル）トリアゾリン－５－オン誘導体、４－（ｎ，ｎ－ジ置換カルバモイル）１－（置換スルホニル）トリアゾリン－５－オン誘導体、およびそれらを有効成分として含有する除草剤
WO2019144969A1 (zh) 2018-01-29 2019-08-01 南京明德新药研发股份有限公司 用于治疗细菌感染的单环β-内酰胺化合物
WO2021121387A1 (zh) 2019-12-19 2021-06-24 南京明德新药研发有限公司 化合物在制药中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
NZ199981A (en) 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
EP0344197B1 (en) 1987-02-11 1991-08-14 The Upjohn Company Novel n-1 substituted beta-lactams as antibiotics
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
EP0357604A1 (en) * 1987-02-27 1990-03-14 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
US4777252A (en) 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4889930A (en) 1987-12-21 1989-12-26 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
EP0336369A1 (en) 1988-04-04 1989-10-11 E.R. Squibb & Sons, Inc. 3-Acylamino-1-[[[(substituted sulfonyl)amino]carbonyl]amino]2-azetidinones
EP0344707A3 (en) 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives
US4959470A (en) 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
WO1990003376A1 (en) 1988-09-27 1990-04-05 The Upjohn Company Dihydroxyaryl 4-substituted monocarbams as antibiotics
CA2210787A1 (en) 1997-07-17 1999-01-17 William R. Collier Self-contained work station
NZ579375A (en) 2007-03-23 2012-02-24 Basilea Pharmaceutica Ag Combination medicaments for treating bacterial infections
WO2010070523A1 (en) * 2008-12-19 2010-06-24 Pfizer Inc. Monocarbams

Also Published As

Publication number Publication date
IL213216A0 (en) 2011-07-31
PA8855001A1 (es) 2010-07-27
KR20110086742A (ko) 2011-07-29
US20120289455A1 (en) 2012-11-15
CA2744756A1 (en) 2010-06-24
AU2009329169A1 (en) 2010-06-24
UY32336A (es) 2010-07-30
EP2379546A1 (en) 2011-10-26
TW201026696A (en) 2010-07-16
AU2009329169B2 (en) 2012-06-28
WO2010070523A1 (en) 2010-06-24
SG171781A1 (en) 2011-07-28
MX2011006541A (es) 2011-07-20
CN102325769A (zh) 2012-01-18
US8324198B1 (en) 2012-12-04
CA2744756C (en) 2013-05-28
US20100160281A1 (en) 2010-06-24
JP2012512863A (ja) 2012-06-07
US8252782B2 (en) 2012-08-28

Similar Documents

Publication Publication Date Title
AR074801A1 (es) Monocarbamas y composiciones farmaceuticas que los contienen
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
PA8852101A1 (es) Nucleótidos uracil ciclopropílicos
BR112012003592B8 (pt) composição farmacêutica contendo derivado de quinolina
RU2018121834A (ru) Новое соединение бифенила или его соль
NZ588994A (en) Phenyl and benzodioxinyl substituted indazoles derivatives
PE20142456A1 (es) COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks
AR071283A1 (es) Compuestos heterociclicos y usos de los mismos
AR065806A1 (es) Derivados de quinolina, procesos para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de la artritis reumatoidea.
MA37712B1 (fr) Inhibiteurs macrocycliques de virus flaviviridae
AR085004A1 (es) Inhibidores selectivos de glicosidasas y usos de los mismos
ECSP12012293A (es) Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos
PE20181519A1 (es) Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido
AR073524A1 (es) Piridopirimidinonas inhibidores de pi3k a y m tor
BR112015001502A2 (pt) derivados de tipo azaindazol ou diazaindazol para tratamento de dor
EA201390626A1 (ru) Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
ES2587304T3 (es) Derivados de diaminopirimidina y procedimientos para la preparación de los mismos
RU2015125591A (ru) БЕНЗИЛСУЛЬФОНАМИДНЫЕ ПРОИЗВОДНЫЕ КАК МОДУЛЯТОРЫ RORc
AR084152A1 (es) Compuestos de triazolopirimidina como inhibidores de pde10a, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades del snc
JP2012512863A5 (es)
PE20141940A1 (es) Compuestos triciclicos, composiciones que los comprenden y usos de los mismos
AR076263A1 (es) Composiciones y metodos para tratar cancer. uso.
AR072802A1 (es) Derivados piperidinicos de esteres de acido bifenil-2-il-carbamico, antagonistas de receptores muscarinicos m3, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de trastornos digestivos,respiratorios y/o urinarios.
AR062131A1 (es) Profarmacos antimicrobianos de oxazolidinona
MX2011012068A (es) Nucleosidos 2'-fluoro arabino y su utilizaicon.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal